(Q40935725)

25 September 2017

1 reference

title

Placebo effects. Issues for clinical practice in psychiatry and medicine (English)

1 reference

25 September 2017

0 references

Straus JL

1

1 reference

PubMed ID

8701009

25 September 2017

von Ammon Cavanaugh S

series ordinal

2

1 reference

25 September 2017

1 July 1996

1 reference

25 September 2017

1 reference

25 September 2017

37

1 reference

25 September 2017

315-326

1 reference

25 September 2017

4

1 reference

A study of the placebo response

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Is there logic in the placebo?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The placebo concept in medicine and psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Effects of placebo administration and occurrence of toxic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Placebo response in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

An evaluation of internal-mammary-artery ligation by a double-blind technic

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Comparison of internal mammary artery ligation and sham operation for angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Placebo response in refractory tardive akathisia.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The placebo response of subfertile couples to attending a tertiary referral centre

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Behavioral and emotional factors and treatment responses in a study of anovulatory infertile women.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Further studies on the pharmacology of placebo administration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Placebo effect in double-blind clinical trials: a review of interactions with medications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Demonstration to medical students of placebo responses and non-drug factors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Study on the effects of tablet colour in the treatment of anxiety states.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

CLASSICAL HEART RATE CONDITIONING IN THE RAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Classic conditioning and placebo effects in crossover studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Expected effect of caffeine on motor performance predicts the type of response to placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The inherent, powerful therapeutic value of a good physician-patient relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

General practice consultations: is there any point in being positive?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The subtractive expectancy placebo procedure: a measure of non-specific factors in behavioural interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The Doctor-Patient Relationship and Malpractice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Harnessing placebo effects in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The mechanism of placebo analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Increased stress and effectiveness of placebos and "active" drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Conditioned placebo responses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Experimental pharmacology and measurement of the subjective response

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Interpreting medical data

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Use of controls in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Double blind: double talk or are there ways to do better research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Side effects and placebo amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Signal and noise in psychotherapy. The role and control of non-specific factors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Predicting response to treatment: differentiating active-factor and non-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Meta-analysis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Regression to the mean in treated versus untreated chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Using meta-analysis in psychiatric research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Surgery as placebo. A quantitative study of bias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Interactions between Pharmacodynamic and Placebo Effects in Drug Evaluations in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Platelet binding characteristics distinguish placebo responders from nonresponders in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The specificity versus nonspecificity dilemma: toward identifying therapeutic change agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Surgery as a placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Effects of a six-week drug holiday on symptom status, relapse, and tardive dyskinesia in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Maintenance Medication for Schizophrenia: Strategies for Dose Reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Intermittent vs maintenance medication in schizophrenia. Two-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Combination therapy for infection due to human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Activists now urge caution on approval of new AIDS drug

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

US AIDS activists urge caution on new anti-HIV drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The continuing unethical use of placebo controls

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

The Helsinki Declaration: timeless guide or irrelevant anachronism?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Fluvoxamine treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Oral sumatriptan in acute migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Dynamics and significance of placebo response in primary dysmenorrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Explanation and management of neurological disability

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Clinical trial of common treatments for low back pain in family practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

Absence of placebo response in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971544-X

7 January 2021

10.1016/S0033-3182(96)71544-X

Identifiers

DOI

0 references

PubMed ID

8701009

1 reference

PubMed ID

8701009